Xtant Medical Holdings, Inc. (XTNT)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Development, Manufacture and Marketing of Orthopedic Medical Products & Devices	133.93M	117.27M	91.30M	57.97M	55.26M
Development, Manufacture and Marketing of Orthopedic Medical Products & Devices Growth	14.21%	28.44%	57.50%	4.90%	3.61%
Total	133.93M	117.27M	91.30M	57.97M	55.26M
Total Growth	14.21%	28.44%	57.50%	4.90%	3.61%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	122.45M	105.52M	85.86M	57.16M	54.57M
United States Growth	16.04%	22.89%	50.21%	4.75%	4.65%
Rest of World	11.48M	11.75M	5.44M	807.00K	693.00K
Rest of World Growth	-2.29%	115.92%	574.23%	16.45%	-41.76%
Total	133.93M	117.27M	91.30M	57.97M	55.26M
Total Growth	14.21%	28.44%	57.50%	4.90%	3.61%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error